Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Siddharth Shetgeri

Neurological Surgery Westerville, OH Doctor of Osteopathy

NPI 1700164993 CMS profile 1095238

70 S Cleveland Ave, Westerville, OH 43081

Open in the dashboard

General payments

$32,835

159 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Siddharth Shetgeri of Westerville, OH is reported in the CMS Open Payments database as having received $32,835 across 159 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,814 51
2024 General $6,467 43
2023 General $447 7
2022 General $446 5
2021 General $372 6
2020 General $11,682 29
2019 General $8,608 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Siddharth Shetgeri
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Siddharth Shetgeri were reported at $4,814. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Siddharth Shetgeri Neurological Surgery median Middle half National median
2019 $8,608 $582 $138–$3,006 $163
2020 $11,682 $294 $76–$2,174 $114
2021 $372 $387 $105–$2,432 $132
2022 $446 $542 $139–$2,989 $149
2023 $447 $534 $145–$2,697 $160
2024 $6,467 $574 $155–$3,046 $164
2025 $4,814 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Aesculap Implant Systems, LLC $17,558 36 payments
  2. Abbott Laboratories $3,104 18 payments
  3. Medtronic, Inc. $2,268 30 payments
  4. Cerapedics, Inc. $2,118 8 payments
  5. SI-BONE, Inc. $1,922 17 payments
  6. Medtronic USA, Inc. $1,880 2 payments
  7. Medacta USA, Inc. $1,094 6 payments
  8. Cosa Medical, LLC $459 1 payment
  9. Boston Scientific Corporation $379 16 payments
  10. Saluda Medical Americas, Inc. $333 2 payments
  11. Other $1,720 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $14,534 31 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,283 5 payments
  3. Food and Beverage $7,556 120 payments
  4. Grant $1,875 1 payment
  5. Honoraria $500 1 payment
  6. Consulting Fee $88 1 payment
Products named General payments · program years 2019–2025
  1. ENNOVATE SPINAL SYSTEM $16,354 25 payments
  2. PROCLAIM $2,234 8 payments
  3. SYNCHROMED $1,875 1 payment
  4. I-FACTOR PEPTIDE ENHANCED BONE GRAFT $1,618 7 payments
  5. ACTIVL ARTIFICIAL DISC $1,255 10 payments
  6. IFUSE IMPLANT SYSTEM $1,119 5 payments
  7. MySpine $1,094 6 payments
  8. INTELLIS ADAPTIVESTIM $822 10 payments
  9. i-FACTOR Putty $500 1 payment
  10. ETERNA $479 6 payments
  11. Other $3,961 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

76

Median for Neurosurgery: 83

Drug cost

$432

Median for Neurosurgery: $872

Branded share of claims

25%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cyclobenzaprine Hcl Generic 28 $193
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 19 $156
Methylprednisolone Generic 18 $54
Tramadol Hcl Generic 11 $28

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$190,505

Medicare's payments for the services billed

Medicare patients

214

Average age 71

Services billed

827

101 women, 113 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 35%
Depression 32%
Ischemic heart disease 31%
Chronic kidney disease 23%
Atrial fibrillation 16%
Osteoporosis 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

159 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record